http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2687401-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6c4a465d018d8fab3fc6d0858b74061 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7155 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df13fbf0254c0fc27e8ff18af16986b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12597b0775af387273e05e3eb669754b |
| publicationDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2687401-T3 |
| titleOfInvention | Prediction of the risk of serious adverse cardiac events |
| abstract | A procedure for determining the risk of death of a subject with heart failure, the procedure comprising: (a) determining a first risk score of severe adverse cardiac episode (MACERS) for a subject with heart failure based, at least in part, on the relationship of a second level of soluble gene 2 expressed for growth stimulation (ST2) in the subject at a second time point (ST2 T1) with a first level of soluble ST2 in the subject at a first time point (ST2 T0), in addition to a weighted Neperian logarithm of a proBNP N-terminal level (NP) in the subject at the second time point (NP T1) according to the following formula: First MACERS> = (ST2 T1 / ST2 T0) + αln ( NP T1), in which α is a weighting factor; (b) determine a second MACERS for a subject based, at least in part, on the relationship of a third level of soluble ST2 in the subject at a third time point (ST2 T2) with ST2 T0, in addition to a weighted Neperian logarithm of a level of NP in the subject at the third time point (NP T2) according to the following formula Second MACERS> = (ST2 T2 / ST2 T0) + αln (NP T2), in which α is a weighting factor; (c) compare the second MACERS with the first MACERS; and (d) determine the risk of death of the subject based on the comparison of the second MACERS with the first MACERS. |
| priorityDate | 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.